| Dr Scott Keith Graupner, DO | |
|
222 E Medical Ln Ste 400, West Columbia, SC 29169-4848 | |
| (803) 794-7511 | |
| (803) 794-7751 |
| Full Name | Dr Scott Keith Graupner |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 11 Years |
| Location | 222 E Medical Ln Ste 400, West Columbia, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821438714 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 83035 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Of Lexington | Lexington, SC | Home health agency |
| Lexington Medical Center | West columbia, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lexington Health Inc | 2567872070 | 753 |
News Archive
From Thanksgiving to New Year's, there are many wishes for everyone to have a blissful and celebratory holiday season. But for many people, the holidays bring more misery than mirth, particularly at a time when the ailing economy can't seem to recover quickly enough and money worries remain on people's minds.
The diagnosis and treatment of cancer does not only trigger posttraumatic stress disorder in adults and older children; infants and toddlers with cancer also suffer from trauma disorders, as researchers from the University of Zurich and the University Children's Hospital Zurich show for the first time. This discovery should be taken into account while treating children to prevent them from developing long-term psychological disorders.
Former Vice President Joe Biden has said if he's elected president he would build on the Affordable Care Act rather than move to a whole new health care system, such as the "Medicare for All" plan supported by some of his primary opponents for the Democratic nomination.
Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced new results from its Phase 1 open-label, dose-escalation trial of LOXO-101, a selective inhibitor of tropomyosin receptor kinase (TRK) signaling molecules, and the first preclinical data for its RET and FGFR programs. The data are being presented at the 2015 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.
› Verified 9 days ago
| Entity Name | Lexington Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710634753 PECOS PAC ID: 2567872070 Enrollment ID: O20201208000922 |
News Archive
From Thanksgiving to New Year's, there are many wishes for everyone to have a blissful and celebratory holiday season. But for many people, the holidays bring more misery than mirth, particularly at a time when the ailing economy can't seem to recover quickly enough and money worries remain on people's minds.
The diagnosis and treatment of cancer does not only trigger posttraumatic stress disorder in adults and older children; infants and toddlers with cancer also suffer from trauma disorders, as researchers from the University of Zurich and the University Children's Hospital Zurich show for the first time. This discovery should be taken into account while treating children to prevent them from developing long-term psychological disorders.
Former Vice President Joe Biden has said if he's elected president he would build on the Affordable Care Act rather than move to a whole new health care system, such as the "Medicare for All" plan supported by some of his primary opponents for the Democratic nomination.
Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced new results from its Phase 1 open-label, dose-escalation trial of LOXO-101, a selective inhibitor of tropomyosin receptor kinase (TRK) signaling molecules, and the first preclinical data for its RET and FGFR programs. The data are being presented at the 2015 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott Keith Graupner, DO Po Box 6069, West Columbia, SC 29171-6069 Ph: (803) 794-7511 | Dr Scott Keith Graupner, DO 222 E Medical Ln Ste 400, West Columbia, SC 29169-4848 Ph: (803) 794-7511 |
News Archive
From Thanksgiving to New Year's, there are many wishes for everyone to have a blissful and celebratory holiday season. But for many people, the holidays bring more misery than mirth, particularly at a time when the ailing economy can't seem to recover quickly enough and money worries remain on people's minds.
The diagnosis and treatment of cancer does not only trigger posttraumatic stress disorder in adults and older children; infants and toddlers with cancer also suffer from trauma disorders, as researchers from the University of Zurich and the University Children's Hospital Zurich show for the first time. This discovery should be taken into account while treating children to prevent them from developing long-term psychological disorders.
Former Vice President Joe Biden has said if he's elected president he would build on the Affordable Care Act rather than move to a whole new health care system, such as the "Medicare for All" plan supported by some of his primary opponents for the Democratic nomination.
Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced new results from its Phase 1 open-label, dose-escalation trial of LOXO-101, a selective inhibitor of tropomyosin receptor kinase (TRK) signaling molecules, and the first preclinical data for its RET and FGFR programs. The data are being presented at the 2015 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.
› Verified 9 days ago
Dr. Robert Anthony Leonardi, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2728 Sunset Blvd Ste 300, West Columbia, SC 29169 Phone: 803-744-4940 Fax: 803-744-4938 | |
Dr. Vijaya Korrapati, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 222 E Medical Ln Ste 400, West Columbia, SC 29169 Phone: 803-794-7511 Fax: 803-794-7751 | |
Parthivkumar N Kundaria, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2720 Sunset Blvd, West Columbia, SC 29169 Phone: 803-791-2480 Fax: 803-936-4102 | |
Jonathan Kyle Hewett, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2728 Sunset Blvd Ste 300, West Columbia, SC 29169 Phone: 803-744-4940 Fax: 803-744-4938 | |
Dr. Carl A White, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 146 N Hospital Drive, Suite 530, West Columbia, SC 29169 Phone: 803-796-7270 Fax: 803-796-0106 | |
Perrie L Ryan, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 222 E Medical Ln Ste 400, West Columbia, SC 29169 Phone: 803-794-7511 Fax: 803-794-7751 | |
Dr. Christopher Patrick Rowley, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2728 Sunset Blvd Ste 300, West Columbia, SC 29169 Phone: 803-744-4940 Fax: 803-744-4938 |